BeOne Medicines Ltd (6160N) Q4 2025 Earnings Report
MX:6160N Q4 2025 EPS Results
- Actual EPS
- MXN 0.86
- Consensus EPS
- MXN 1.79
- Beat/Miss
- Missed by -MXN 0.92
- One Year Ago EPS
- -MXN 2.05
MX:6160N Q4 2025 Revenue Results
- Actual Revenue
- MXN 27.91B
- Expected Revenue
- MXN 27.40B
- Beat/Miss
- Beat by +MXN 510.59M
- YoY Revenue Growth
- +32.89%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 03/25/2026
- Time
- Before Open
- Conference Call
- Wednesday, March 25, 2026
MX:6160N Upcoming Earnings
BeOne Medicines Ltd's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:6160N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | 2.75- | 1.56 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 2.402.96 | 1.32 | 125.32% (+1.65) | |
| May 06, 2026 | 2026 (Q1) | 1.402.83 | 0 | ― | |
| Mar 25, 2026 | 2025 (Q4) | 1.790.86 | -2.05 | 142.22% (+2.91) | |
| Nov 06, 2025 | 2025 (Q3) | 1.301.56 | -1.65 | 194.77% (+3.21) | |
| Aug 28, 2025 | 2025 (Q2) | 0.601.32 | -1.65 | 179.57% (+2.97) | |
| May 07, 2025 | 2025 (Q1) | -0.910.00 | -3.47 | 100.00% (+3.47) | |
| Feb 27, 2025 | 2024 (Q4) | -1.45-2.05 | -5.09 | 59.75% (+3.04) | |
| Nov 12, 2024 | 2024 (Q3) | -1.60-1.65 | 2.89 | -156.95% (-4.54) | |
| Aug 26, 2024 | 2024 (Q2) | -3.15-1.65 | -5.23 | 68.42% (+3.58) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
